Scientists found that doxorubicin treatment significantly induced RNA m6A methylation in breast cancer cells in both a dose- and time-dependent manner.
[Molecular Therapy]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters Mammary Cell News PRMT5 Regulates RNA M6A Demethylation for Doxorubicin Sensitivity in Breast Cancer
